The technology of organ preservation has improved considerably and being constantly modified to provide improved organ storage and outcomes. Several organ-preservation solutions are available and are currently used for kidney, liver, pancreas, small-bowel, lung, and heart transplantations. These solutions provide an artificial medium to the organs that help maintain their survival duration outside the human body before transplantation into a patient. The major solutions available in the market include Viaspan, Custodiol HTK, Renograf, Hypothermosol, Perfadex, Lifor, siRNA transplant solution, HBS solution and others. Technologically advanced solutions, rise in the number of elderly people and presence of effective reimbursement policies are the major factors driving the growth of the global organ preservation solutions market.
The global organ preservation solutions market segmentation is based on solution (Viaspan, Custodiol HTK Solution, Renograf, Hypothermosol, Perfadex, Lifor, Human bioSystem solution, siRNA Transplant solution, etc.), and its preservation techniques (hypothermic perfusion preservation, static cold storage, etc.).
The global organ preservation solutions market report provides market size (Revenue US$ Million 2014 to 2021), market share, market trends and forecasts growth trends (CAGR%, 2017 to 2021).
The global organ preservation solutions market report also provides the detailed market landscape, market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global organ preservation solutions market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
Major players operating in the global organ preservation solutions market and included in this report are Bristol-Myers Squibb, BioLife Solutions, Dr. Franz Köhler Chemie GmbH, Teva Pharmaceutical Industries Ltd., Inc., ToleroTech, Inc., and XVIVO Perfusion AB.